Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > FORMAL TAKEOVER BID.

<< Previous

Bullboard Posts

Next >>

Comment by Solid1on Dec 15, 2024 5:55pm

91 Views

Post# 36363370

RE:RE:RE:RE:RE:RE:FORMAL TAKEOVER BID.

Of course something will come... the only reason CBD was quiet for years was because of NCE exclusivity, which made it impossible to approve new therapies or new CBD-based drugs. It is no coincidence that all applications for approval coincide exactly with the expiry of this exclusivity. And as for Pidduck, there is nothing strange in his resume so why this accusation?

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?